Project Grant HT94252510855
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $1.9M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
- The Defense Health Agency awarded a $699,901 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Health Services Research (MHSR) Program (CFDA 12.007). The grant period runs from September 30, 2025 to September 29, 2027. The purpose of the grant is to characterize and quantify specialty care utilization and clinical and military-related outcomes following limb loss among active duty service members from 2003 to 2023. This research...
- The Defense Health Agency awarded a $856,523 Project Grant to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low therapy,...
- This $2,402,721 Project Grant was awarded on April 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports the development of a patient monitoring and decision-support platform for precision health applications, with a performance period from April 15, 2025 to April 14, 2027. The grant aims to advance biomedical research and innovative...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- The Defense Health Agency awarded a $488,086 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS," is intended to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The performance period...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- This $1,460,695 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities" at The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. over the period of September 1, 2025 to August 31, 2028. The project aims to transform healthcare for military service members, veterans, and...
- The federal Project Grant award of $1,333,483.00 from the Defense Health Agency's Military Health Services Research (MHSR) Program (CFDA 12.007) supports research by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to develop efficient measures and effective solutions for addressing burnout among military medical personnel. The project aims to enhance the effectiveness and efficiency of the Military Health System in providing comprehensive healthcare to its 9.5...
- This federal Project Grant award of $6,381,198 from the Defense Health Agency was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on August 1, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives to improve health outcomes for military personnel, veterans, and the public. The "GET BETTER TOGETHER: A PRIMARY PREVENTION INTERVENTION FOR MILITARY...
- The Defense Health Agency awarded a $1,390,847 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant, titled "INVESTIGATING THE MECHANISTIC ROLE AND THERAPEUTIC TARGETING OF COHESIN RAD21 IN METASTATIC PROSTATE CANCER", runs from September 1, 2025 to August 31, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military...
The Defense Health Agency awarded a $1,943,628.00 Project Grant titled "INCREASING ACCESS TO EVIDENCE-BASED BEHAVIORAL HEALTH TREATMENTS FOR INSOMNIA IN THE MHS" to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant will fund research and development efforts to improve access to evidence-based insomnia treatments within the Military Health System over the award period from September 1, 2025 to August 31, 2029.
Generated 10/21/25, 5:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.9m | 8/7/25 |